Effect of nifedipine on allergen-induced bronchoconstriction. 1986

N Crimi, and F Palermo, and F Gibellino, and C Vancheri, and B Palermo, and R Oliveri, and A Mistretta

The effect of nifedipine on allergen-induced asthma in nine asthmatic subjects was studied. All subjects had a history of asthma and positive Prick test; lyophilized allergen extracts of Dermatophagoides Pteronyssinus were used. All solutions were inhaled through DeVilbiss nebulizer. On the first day baseline FEV1 value was measured, allergen extracts were inhaled at increasing doses. The procedure was repeated until a 20% fall from the baseline FEV1 was obtained. Nifedipine or placebo capsules were administered sublingually in a randomized double blind manner. Antigen challenge was given 30 minutes later by using provocating dose of allergen. The change in FEV1 value was calculated from the post nifedipine administration. A significant negative correlation (p less than 0.01) was found between the percentage of protection and the baseline PD20. Nifedipine produced a significant mean change of the bronchial reactivity threshold (p less than 0.01).

UI MeSH Term Description Entries
D008297 Male Males
D009543 Nifedipine A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure. Adalat,BAY-a-1040,Bay-1040,Cordipin,Cordipine,Corinfar,Fenigidin,Korinfar,Nifangin,Nifedipine Monohydrochloride,Nifedipine-GTIS,Procardia,Procardia XL,Vascard,BAY a 1040,BAYa1040,Bay 1040,Bay1040,Monohydrochloride, Nifedipine,Nifedipine GTIS
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D001980 Bronchi The larger air passages of the lungs arising from the terminal bifurcation of the TRACHEA. They include the largest two primary bronchi which branch out into secondary bronchi, and tertiary bronchi which extend into BRONCHIOLES and PULMONARY ALVEOLI. Primary Bronchi,Primary Bronchus,Secondary Bronchi,Secondary Bronchus,Tertiary Bronchi,Tertiary Bronchus,Bronchi, Primary,Bronchi, Secondary,Bronchi, Tertiary,Bronchus,Bronchus, Primary,Bronchus, Secondary,Bronchus, Tertiary
D001985 Bronchial Provocation Tests Tests involving inhalation of allergens (nebulized or in dust form), nebulized pharmacologically active solutions (e.g., histamine, methacholine), or control solutions, followed by assessment of respiratory function. These tests are used in the diagnosis of asthma. Allergen Bronchial Provocation Tests,Allergen Challenge, Endobronchial,Antigen Bronchial Provocation Tests,Bronchial Allergen Challenge,Bronchial Challenge Tests,Inhalation Provocation Tests,Provocation Tests, Bronchial,Endobronchial Challenge Tests,Allergen Challenge, Bronchial,Allergen Challenges, Bronchial,Allergen Challenges, Endobronchial,Bronchial Allergen Challenges,Bronchial Challenge Test,Bronchial Provocation Test,Challenge Test, Bronchial,Challenge Test, Endobronchial,Challenge Tests, Bronchial,Challenge Tests, Endobronchial,Challenge, Bronchial Allergen,Challenge, Endobronchial Allergen,Challenges, Bronchial Allergen,Challenges, Endobronchial Allergen,Endobronchial Allergen Challenge,Endobronchial Allergen Challenges,Endobronchial Challenge Test,Inhalation Provocation Test,Provocation Test, Bronchial,Provocation Test, Inhalation,Provocation Tests, Inhalation,Test, Bronchial Challenge,Test, Bronchial Provocation,Test, Endobronchial Challenge,Test, Inhalation Provocation,Tests, Bronchial Challenge,Tests, Bronchial Provocation,Tests, Endobronchial Challenge,Tests, Inhalation Provocation
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005260 Female Females
D005541 Forced Expiratory Volume Measure of the maximum amount of air that can be expelled in a given number of seconds during a FORCED VITAL CAPACITY determination . It is usually given as FEV followed by a subscript indicating the number of seconds over which the measurement is made, although it is sometimes given as a percentage of forced vital capacity. Forced Vital Capacity, Timed,Timed Vital Capacity,Vital Capacity, Timed,FEVt,Capacities, Timed Vital,Capacity, Timed Vital,Expiratory Volume, Forced,Expiratory Volumes, Forced,Forced Expiratory Volumes,Timed Vital Capacities,Vital Capacities, Timed,Volume, Forced Expiratory,Volumes, Forced Expiratory
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

N Crimi, and F Palermo, and F Gibellino, and C Vancheri, and B Palermo, and R Oliveri, and A Mistretta
January 1983, Agents and actions. Supplements,
N Crimi, and F Palermo, and F Gibellino, and C Vancheri, and B Palermo, and R Oliveri, and A Mistretta
March 1983, Clinical allergy,
N Crimi, and F Palermo, and F Gibellino, and C Vancheri, and B Palermo, and R Oliveri, and A Mistretta
May 1983, The American review of respiratory disease,
N Crimi, and F Palermo, and F Gibellino, and C Vancheri, and B Palermo, and R Oliveri, and A Mistretta
November 1988, Arerugi = [Allergy],
N Crimi, and F Palermo, and F Gibellino, and C Vancheri, and B Palermo, and R Oliveri, and A Mistretta
October 1985, The Journal of allergy and clinical immunology,
N Crimi, and F Palermo, and F Gibellino, and C Vancheri, and B Palermo, and R Oliveri, and A Mistretta
July 1983, Thorax,
N Crimi, and F Palermo, and F Gibellino, and C Vancheri, and B Palermo, and R Oliveri, and A Mistretta
April 1989, Journal of applied physiology (Bethesda, Md. : 1985),
N Crimi, and F Palermo, and F Gibellino, and C Vancheri, and B Palermo, and R Oliveri, and A Mistretta
February 1992, Annals of allergy,
N Crimi, and F Palermo, and F Gibellino, and C Vancheri, and B Palermo, and R Oliveri, and A Mistretta
June 1993, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology,
N Crimi, and F Palermo, and F Gibellino, and C Vancheri, and B Palermo, and R Oliveri, and A Mistretta
January 2008, Pulmonary pharmacology & therapeutics,
Copied contents to your clipboard!